|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 23180 |
FusionGeneSummary for MYO6_CRYL1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MYO6_CRYL1 | Fusion gene ID: 23180 | Hgene | Tgene | Gene symbol | MYO6 | CRYL1 | Gene ID | 4646 | 51084 |
| Gene name | myosin VI | crystallin lambda 1 | |
| Synonyms | DFNA22|DFNB37|Myo6-007|Myo6-008 | GDH|HEL30|gul3DH|lambda-CRY | |
| Cytomap | 6q14.1 | 13q12.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | unconventional myosin-VImyosin VI transcript variant 007myosin VI transcript variant 008unconventional myosin-6 | lambda-crystallin homologL-gulonate 3-dehydrogenasecrystallin, lamda 1epididymis luminal protein 30testicular tissue protein Li 44 | |
| Modification date | 20180527 | 20180524 | |
| UniProtAcc | Q9UM54 | Q9Y2S2 | |
| Ensembl transtripts involved in fusion gene | ENST00000369981, ENST00000369985, ENST00000369977, ENST00000369975, ENST00000462633, | ENST00000298248, ENST00000382812, ENST00000480748, | |
| Fusion gene scores | * DoF score | 9 X 8 X 8=576 | 8 X 5 X 6=240 |
| # samples | 17 | 8 | |
| ** MAII score | log2(17/576*10)=-1.76053406530461 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/240*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: MYO6 [Title/Abstract] AND CRYL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | MYO6 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 16507995 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | MESO | TCGA-MQ-A4KX-01A | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-3CDS | ENST00000369981 | ENST00000298248 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| 5UTR-3CDS | ENST00000369981 | ENST00000382812 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| 5UTR-intron | ENST00000369981 | ENST00000480748 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| 5UTR-3CDS | ENST00000369985 | ENST00000298248 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| 5UTR-3CDS | ENST00000369985 | ENST00000382812 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| 5UTR-intron | ENST00000369985 | ENST00000480748 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| 5UTR-3CDS | ENST00000369977 | ENST00000298248 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| 5UTR-3CDS | ENST00000369977 | ENST00000382812 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| 5UTR-intron | ENST00000369977 | ENST00000480748 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| intron-3CDS | ENST00000369975 | ENST00000298248 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| intron-3CDS | ENST00000369975 | ENST00000382812 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| intron-intron | ENST00000369975 | ENST00000480748 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| intron-3CDS | ENST00000462633 | ENST00000298248 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| intron-3CDS | ENST00000462633 | ENST00000382812 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
| intron-intron | ENST00000462633 | ENST00000480748 | MYO6 | chr6 | 76459140 | + | CRYL1 | chr13 | 20987526 | - |
Top |
FusionProtFeatures for MYO6_CRYL1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MYO6 | CRYL1 |
| Myosins are actin-based motor molecules with ATPaseactivity. Unconventional myosins serve in intracellular movements.Myosin 6 is a reverse-direction motor protein that moves towardsthe minus-end of actin filaments. Has slow rate of actin-activatedADP release due to weak ATP binding. Functions in a variety ofintracellular processes such as vesicular membrane trafficking andcell migration. Required for the structural integrity of the Golgiapparatus via the p53-dependent pro-survival pathway. Appears tobe involved in a very early step of clathrin-mediated endocytosisin polarized epithelial cells. May act as a regulator of F-actindynamics. May play a role in transporting DAB2 from the plasmamembrane to specific cellular targets. Required for structuralintegrity of inner ear hair cells (By similarity). {ECO:0000250,ECO:0000269|PubMed:10519557, ECO:0000269|PubMed:11447109,ECO:0000269|PubMed:16507995, ECO:0000269|PubMed:16949370}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MYO6_CRYL1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MYO6_CRYL1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| MYO6 | DAB2, GIPC1, CALM2, DAB1, CYLD, USP11, USP25, CDC42, APC, UBC, SP1, TAX1BP1, CALCOCO2, FBXO25, OPTN, LMTK2, AP2A1, CLTC, PAK1, CAPZA1, POLR2A, ESR1, RNF11, TOM1, TOM1L2, MYO6, PARK2, PAN2, FBXO6, TP53, ENO1, MOV10, NXF1, ALK, ABCE1, CDH1, NTRK1, DPP9, DNAJC2, G6PD, PAK2, RAD23A, RAD23B, NHLRC2, CAPZA2, CDK2, CLTB, DBN1, FLNA, GAK, MYH9, PPP1CB, PICALM, ACTR2, SYNPO, GTSE1, ANLN, MYO5C, MYO19, MYO18A, CFTR, RNF126, UBXN1, SEC16A, AP2B1, AP2A2, AP2M1, CLINT1, PIK3C2A, EPS15, REPS2, COPB2, DDB1, EPRS, VPRBP, DCTN1, GTPBP4, ARHGEF12, YTHDC2, DCTN2, DOCK7, POTEI, FBXO34, PPP1R9A, CUEDC1, FBXO30, TMOD2, ACTBL2, GSN, REPS1, WBP2, COX15, DLST, HSD17B10, PDHA1, G3BP1 | CRYL1 | ELAVL1, ABCC6, F2R, PKD2, TRIM65, HTT, SPG11, ANAPC5, C5orf34, DYNC2H1, SMG7, HAUS5, USP19, CEP164, PIK3C2A, IFT122, CDC23, TBCD, STIL, IFT140, UBR4, SMG8, ALMS1, HAUS3, MYO9A, WDR59, TTC37, WRAP53, HOOK1, ANAPC1, BRIP1, USP54, PLD2, TRIM32, MYO5C, EIF2AK4 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MYO6_CRYL1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MYO6_CRYL1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | MYO6 | C2931767 | Deafness, autosomal dominant nonsyndromic sensorineural 22 | 2 | CTD_human;ORPHANET;UNIPROT |
| Hgene | MYO6 | C0236969 | Substance-Related Disorders | 1 | CTD_human |
| Hgene | MYO6 | C1843028 | Deafness, Autosomal Recessive 37 | 1 | CTD_human;UNIPROT |
| Tgene | CRYL1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Tgene | CRYL1 | C0520459 | Necrotizing Enterocolitis | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|